Current and future use of aminodihydrophthalazindione sodium in patients with COVID-19, including for «cytokine storm» therapy

Abstract

There are no data on the clinical efficacy of the preparation containing sodium aminodihydrophthalazindione in «cytokine storm», including in patients with COVID-19. Protocols of planned or ongoing clinical trials of a preparation containing sodium aminodihydrophthalazindione at COVID-19 have not been found. The use of sodium aminodihydrophthalazindione in the treatment of COVID-19 is possible only in clinical trials.

Keywords

• коронавирус
• аминодигидрофталазиндион натрия
• covid-19
• цитокиновый шторм